All news

LAB director buys 75,000 shares near 52-week low

Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash

Thomas D. Carey, a director at Standard BioTools Inc. (NASDAQ:LAB), recently purchased 75,000 shares of the company's common stock for $46,897 at a price of $0.6253 each. This transaction occurred on November 5, 2026, when the stock was trading near its 52-week low. Following this acquisition, Mr. Carey now directly holds 419,456 shares of Standard BioTools.

Read original source

LAB company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.